You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MLYS Sale Disclosure
Rodman David Malcom · SEC Form 4 · Filed Jun 17, 2026
Sale
Calculated transaction value
$235.49K
Rodman David Malcom Chief Medical Officer
MLYS
Transaction date
Jun 15, 2026
Public filing date
Jun 17, 2026
Filing lag
Filed 2 days later
MLYS daily price context
Close on/before transaction
$23.92
Jun 15, 2026
First close after public filing
$24.63
Jun 18, 2026
30-day return after filing
+9.99%
Through Jul 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 9,890 shares @ $23.81
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001933414-26-000094
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$452.03K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Mineralys Therapeutics, Inc. MLYS | Exercise | Jun 17, 2026 | $0 |
| Mineralys Therapeutics, Inc. MLYS | Exercise | Jun 17, 2026 | $6.44K |
| Mineralys Therapeutics, Inc. MLYS | Sale | Jun 17, 2026 | $114.6K |
| Mineralys Therapeutics, Inc. MLYS | Exercise | Jun 17, 2026 | $0 |
| Mineralys Therapeutics, Inc. MLYS | Exercise | Jun 17, 2026 | $59.38K |
| Mineralys Therapeutics, Inc. MLYS Current | Sale | Jun 15, 2026 | $235.49K |
| Mineralys Therapeutics, Inc. MLYS | Exercise | Jun 15, 2026 | $36.13K |
| Mineralys Therapeutics, Inc. MLYS | Exercise | Jun 15, 2026 | $0 |